Day: March 2, 2023

What’s New in Multiple Myeloma Management?

Multiple myeloma is diagnosed in over 100,000 patients each year worldwide. The FDA recently granted accelerated approval to Teclistamab, the first bispecific B-cell maturation (BCMA)-directed CD3 T-cell engager. buy prednisone online https://rxxbuynoprescriptiononline.com/buy-prednisone.html no prescription pharmacy The therapeutic armamentarium for myeloma…